Suchergebnisse - (Person:"Rizk, John G")

PubPharm (7)

1

To Anticoagulate or Not to Anticoagulate in COVID-19 : Lessons after 2 Years

enthalten in: Seminars in thrombosis and hemostasis | 2023

von Rizk, J. | Gupta, A. | Lazo, J. | +4

2

Coronavirus disease 2019, hypertension, and renin-angiotensin-aldosterone system inhibitors

enthalten in: Current opinion in cardiology | 2022

von Rizk, J. | Sanchis-Gomar, F. | Henry, B. | +2

3

Ramatroban for chemoprophylaxis and treatment of COVID-19 : David takes on Goliath

enthalten in: Expert opinion on therapeutic targets | 2022

von Chiang, K. | Rizk, J. | Nelson, D. | +6

4

Mechanisms and management of drug-induced hyperkalemia in kidney transplant patients

enthalten in: Reviews in endocrine & metabolic disorders | 2021

von Rizk, J. | Lazo, J. | Quan, D. | +5

5

Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis : A Review

enthalten in: JAMA cardiology | 2021

von Rizk, J. | Gupta, A. | Sardar, P. | +4

6

Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic

enthalten in: Drug discovery today | 2021

von Rizk, J. | Forthal, D. | Kalantar-Zadeh, K. | +5

7

Pharmaco-Immunomodulatory Therapy in COVID-19

enthalten in: Drugs | 2020

von Rizk, J. | Kalantar-Zadeh, K. | Mehra, M. | +3

CommentIn: Drugs. 2020 Sep;80(14):1499-1500. - PMID 32880807

1
[1]